According to the AB/CD algorithm,12 both treatment arms of NOAAH included a drug class that addressed the low-renin volume component of hypertension (hydrochlorothiazide and amlodipine) as well as an agent (bisoprolol and valsartan) interfering with the high-renin vasoconstrictor component. This evidence concerns the gene REN and hypertensive disorder.